702 related articles for article (PubMed ID: 34758532)
1. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
2. Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis.
Ye J; Lin Y; Wang Q; Li Y; Zhao Y; Chen L; Wu Q; Xu C; Zhou C; Sun Y; Ye W; Bai F; Zhou T
Front Endocrinol (Lausanne); 2020; 11():601745. PubMed ID: 33324350
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
4. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
[No Abstract] [Full Text] [Related]
5. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
Wang J; Liu H; Xie G; Cai W; Xu J
Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis.
Jiang ZY; Zhou Y; Zhou L; Li SW; Wang BM
Biomed Res Int; 2021; 2021():7561645. PubMed ID: 34552988
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery.
Chen F; Zhou Y; Wu Z; Li Y; Zhou W; Wang Y
Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714
[TBL] [Abstract][Full Text] [Related]
8. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
[TBL] [Abstract][Full Text] [Related]
9. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.
Ma M; Xie W; Li X
Int J Gen Med; 2021; 14():3163-3176. PubMed ID: 34262330
[TBL] [Abstract][Full Text] [Related]
10. Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
Fan GH; Wei RL; Wei XY; Zhang CZ; Qi ZT; Xie HY; Zheng SS; Xu X
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):433-451. PubMed ID: 34233850
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer.
Qiu T; Hu W; Rao Z; Fang T
Front Genet; 2022; 13():1007337. PubMed ID: 36568397
[No Abstract] [Full Text] [Related]
12. Microarray-Based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease: A Protein-Protein Interaction Network Analysis.
Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37194229
[TBL] [Abstract][Full Text] [Related]
13. [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis].
Chen YH; Zhan Z; Hu P; Ren H; Peng ML
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):533-540. PubMed ID: 31357780
[No Abstract] [Full Text] [Related]
14. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
He R; Guan C; Zhao X; Yu L; Cui Y
Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
[TBL] [Abstract][Full Text] [Related]
15. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
[TBL] [Abstract][Full Text] [Related]
17. Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis.
Wang W; Gao X; Kang N; Wang C; Li C; Yu H; Zhang X
Sci Rep; 2023 Oct; 13(1):18497. PubMed ID: 37898694
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease.
Wang R; Wang X; Zhuang L
Ann Hepatol; 2016; 15(2):190-9. PubMed ID: 26845596
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis.
Lu H; Ma J; Li Y; Zhang J; An Y; Du W; Cai X
Front Mol Biosci; 2023; 10():1164220. PubMed ID: 37405258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
